Clinician-rated functioning and patient-rated quality of life in schizophrenia: implications of their correspondence for psychopathology and side effects
- PMID: 19931586
- DOI: 10.1016/j.pnpbp.2009.11.012
Clinician-rated functioning and patient-rated quality of life in schizophrenia: implications of their correspondence for psychopathology and side effects
Abstract
Objective: Past studies have found inconsistent associations between subjective and objective measures of quality of life (QOL) in schizophrenia. We hypothesized that this may be due to heterogeneity in the demographic and/or clinical variables inherent in the samples and we investigated this possibility.
Methods: We stratified the patients according to a descriptive measure of correspondence between self-reported QOL and clinician-rated functioning. We then examined whether heterogeneous patterns existed among the subgroups in terms of demographic variables, symptom severity, associations between self-reported and clinician-rated psychopathology and associations between side effects, QOL and functioning.
Results: The subgroups significantly differed with respect to clinician-rated positive symptoms (F=3.075, p<.05), subjective symptoms (somatization, F=5.768, p<.01; obsessive-compulsive, F=3.885, p<.05; interpersonal sensitivity, F=8.278, p<.001; depression, F=9.368, p<.001; anxiety, F=6.909, p<.01; hostility, F=7.787, p<.01; phobic anxiety, F=9.551, p<.001; paranoia, F=5.304, p<.01; psychoticism, F=5.071, p<.01) and in- and outpatient ratio (Chi(2)=11.58, p<.01). Only the subgroup with relatively good correspondence between clinician-rated functioning and self-reported QOL showed significant low to moderate associations between the aforementioned measures and side effects. In addition, they showed similar levels of significant associations between the positive and subjective symptoms. In contrast, other discordant subgroups lacked overall associations between side effects, functioning and QOL as well as between subjective and objective measures of psychopathology.
Conclusion: Low to moderate levels of correspondence between subjective QOL and objective functioning were partly supportive of the independence of the constructs. Insight is likely to be a mediating variable of the correspondence between self-report and clinician-rated measures and should be considered in studies using self-report measures.
Copyright 2009. Published by Elsevier Inc.
Similar articles
-
[Relationship between insight and self-reported quality of life among shizophrenic patients].Encephale. 2011 Jun;37(3):162-71. doi: 10.1016/j.encep.2010.08.011. Epub 2010 Oct 20. Encephale. 2011. PMID: 21703431 French.
-
Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.Psychiatry Clin Neurosci. 2009 Aug;63(4):521-8. doi: 10.1111/j.1440-1819.2009.01995.x. Epub 2009 Jun 15. Psychiatry Clin Neurosci. 2009. PMID: 19531107
-
Determinants of subjective quality of life in depressed patients: the role of self-esteem, response styles, and social support.J Affect Disord. 2005 Jun;86(2-3):205-13. doi: 10.1016/j.jad.2005.01.014. J Affect Disord. 2005. PMID: 15935240
-
[Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].Encephale. 2003 Mar-Apr;29(2):137-47. Encephale. 2003. PMID: 14567165 Review. French.
-
Systematic review of global functioning and quality of life in people with psychotic disorders.Epidemiol Psychiatr Sci. 2019 Feb;28(1):31-44. doi: 10.1017/S2045796018000549. Epub 2018 Oct 1. Epidemiol Psychiatr Sci. 2019. PMID: 30270819 Free PMC article.
Cited by
-
The Effects of Bi-Anodal tDCS Over the Prefrontal Cortex Regions With Extracephalic Reference Placement on Insight Levels and Cardio-Respiratory and Autonomic Functions in Schizophrenia Patients and Exploratory Biomarker Analyses for Treatment Response.Int J Neuropsychopharmacol. 2021 Jan 20;24(1):40-53. doi: 10.1093/ijnp/pyaa063. Int J Neuropsychopharmacol. 2021. PMID: 32808025 Free PMC article. Clinical Trial.
-
The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):27-38. doi: 10.1007/s00406-017-0829-3. Epub 2017 Jul 29. Eur Arch Psychiatry Clin Neurosci. 2018. PMID: 28756468
-
Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia.Noro Psikiyatr Ars. 2016 Dec;53(4):328-333. doi: 10.5152/npa.2016.11327. Epub 2016 Dec 1. Noro Psikiyatr Ars. 2016. PMID: 28360807 Free PMC article.
-
Associated factors of quality of life in first-episode schizophrenia patients.Psychiatry Investig. 2011 Sep;8(3):201-6. doi: 10.4306/pi.2011.8.3.201. Epub 2011 Aug 26. Psychiatry Investig. 2011. PMID: 21994506 Free PMC article.
-
Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.Pharmacogenet Genomics. 2013 Feb;23(2):69-77. doi: 10.1097/FPC.0b013e32835ca260. Pharmacogenet Genomics. 2013. PMID: 23241943 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous